Chapter 12 Depression
Introduction
Mental health is closely linked to physical health. Depression (e.g. major depression) is highly prevalent and a major cause of disability. The World Health Organization (WHO) expects that by 2020 depression will rank second only to ischemic heart disease in terms of disability, irrespective of gender and age.1 Currently, depression is ranked as the second cause of disability in terms of disability adjusted life years in the age category 15–44 years for both genders combined.1 Depression is a common illness affecting at least 1 in 5 people during their lifetime.2 Depression has no gender, age, or lifestyle background predilection, it can potentially occur in all persons. Depression facts:
Patients often present with an overlapping and complex set of symptoms (Table 12.1).
Table 12.1 The spectrum of symptoms in depression3
| Physical symptoms | Emotional symptoms |
|---|---|
| Tiredness and fatigue | Sadness and tearfulness |
| Sleep disturbances | Anxiety and irritability |
| Headaches | Loss of interest |
| Gastrointestinal disturbances | Hopelessness |
| Psychomotor activity changes | Difficulty concentrating |
| Appetite changes | Guilt |
| Body aches and pains | Suicidal tendency |
Depression also influences the morbidity and mortality of a number of somatic illnesses. Research strongly documents a significantly higher risk and mortality in depressed patients post acute myocardial infarction.4 There is also evidence demonstrating that depression is significantly associated with diabetics.5
Complementary medicine (CM) encompasses a wide range of therapies that are currently not part of conventional medicine and are often adopted by patients who feel the need to take more control over their illnesses. Unfortunately, this often leads to patients self-medicating to alleviate symptoms, such as emotional distress, to help them cope with serious mental illness problems.6
A recent review7 has reported that systematic trials are required for promising substances for depression and that meanwhile, those patients wishing to take psychotropic complementary medicines require appropriate medical advice. In this chapter we review the evidence-based research in CM approaches to the treatment of depression, that includes the use of herbal medicines, nutritional and dietary supplements, mind–body medicine approaches such as cognitive behavioural therapy (CBT), meditation, hypnosis, aromatherapy, acupuncture and light therapy.
A recent review of the literature identified a range of possible non-drug treatments for the treatment of depression in the elderly.8 The review found best evidence for antidepressants, electroconvulsive therapy (ECT), CBT, psychodynamic psychotherapy, reminiscence therapy, problem-solving therapy, bibliotherapy and physical exercise. Limited evidence was identified for transcranial magnetic stimulation, dialectical behaviour therapy, interpersonal therapy, light therapy, St John’s wort and folate.
Another review of the literature found the best evidence for the treatment of depression occurred with St John’s wort, exercise, bibliotherapy, CBT and light therapy (for winter depression), and promising evidence (but needing more research) for folate vitamin E, vitamin B6, vitamin D, SAMe (s-adenosyl methionine), phenyalanine, Ginkgo biloba, acupuncture, light therapy (non-seasonal depression), massage therapy, negative air ionisation (for winter depression), relaxation therapy, yoga, and reducing or avoiding alcohol, sugar and caffeine avoidance and possibly music/dance therapy.9
The risk factors for depression are:
Healthy lifestyle changes
In the management of depression, emphasis on lifestyle changes is vital, such as stress management, improved diet, sleep, exercise, sunlight exposure and smoking cessation. The treatment of depression requires the health practitioner to spend long consultations exploring all of these areas.10 A few words of advice can go a long way towards changing patients’ health behaviour.11 A study found that patients were more likely to try to quit smoking, change their diet and perform more exercise when written information leaflets were backed by encouragement and GP advice. The study also concluded that advice on health behaviour may have to be delivered several times before it brought about change.11
Mind–body medicine
Cognitive behavioural therapy (CBT), group therapy and support groups
Counselling and CBT carry the greatest weight of scientific evidence for the treatment of depression.12 The types of psychotherapy that have proven efficacy are mainly CBT and interpersonal psychotherapy (IPT).13, 14
A recent study with depressed mothers demonstrated that brief IPT was beneficial in reducing levels of maternal symptoms of depression and improving functioning at the 3– and 9–month follow-ups compared to usual treatment for depression.12 Moreover, the meta-analysis reported that preventative strategies such as IPT may be more effective than prevention based on CBT.13
The health practitioner needs to be alert to stressors the patient is experiencing in the school, home or work environments. Traumatic and stressful experiences in people’s lives such as relationship breakdowns, loss, bullying, being excluded by peers, experiencing humiliation, life-threatening events, assault (physical and sexual), and loss of work are potent triggers for depression and feelings of suicidal ideation.15–19
The prognosis of depression is worse when the patient has a serious illness such as cancer or heart disease.20, 21
CBT is at least as effective as antidepressants in outpatients with severe depression according to a meta-analysis of 4 major randomised trials.22
Recent reviews23,24 conclude that psychotherapy and pharmacotherapy generally are of comparable efficacy, and both modalities are superior to usual care in treating depression.
CBT has been investigated in a number of clinical scenarios, and demonstrated better efficacy than medication for post-partum depression.25 CBT was efficacious in reducing depressive symptoms among HIV-infected individuals,26 was effective for the treatment of unipolar depression,27 effective in incurable cancer patients,28 and a recent meta-analysis suggests that CBT may be of potential benefit in older people with depression.29 Further, recently it has been reported that CBT may be useful for depressed patients diagnosed with Parkinson’s Disease.30
Young adolescents with depression and repeated self-harm showed promising results in a Group therapy program.31 UK child psychiatrists randomised 63 patients aged 12–16 to routine care or to a weekly group therapy program over 6 months. The adolescents in the group therapy program were less likely to harm themselves, less likely to use health care resources, had better school attendance, and a lower rate of behavioural disorders. However, there was no effect on the severity of the depression or its prevalence.
A comprehensive meta-analysis of the literature of 19 randomised controlled trials (RCTs), meeting the inclusion criteria, highlighted that efficacy of preventive psychological interventions can reduce the incidence of depressive disorders by 22% in experimental groups compared with control groups. Therefore, therapies such as counselling and CBT may also play a role in the prevention of depression onset.14
Stress management
A 12-week, randomised, clinical trial of 123 outpatients who met the DSM-IV criteria for major or minor depression within 1 year after coronary artery bypass surgery significantly improved following 12 weeks of CBT or supportive stress management. The CBT group led to remission of depression at 3 and 9 months in 71% of patients and 57% for those undergoing supportive stress management by 3 months compared with 33% remission in the usual care group. At 9 months remission rates were similar with CBT being far superior to usual care for depression and other secondary psychological outcomes, such as anxiety, hopelessness, stress, and quality of life.32
Meditation
Mindfulness meditation-based stress reduction programs have demonstrated effectiveness in decreasing mood disturbance, including depression and stress symptoms in patients with a wide range of types and stages of cancer.33, 34 A randomised, wait-list controlled design of 90 patients (mean age 51 years, 78% females) was used with the intervention consisting of weekly meditation of 1.5 hours for 7 weeks plus home meditation practice.33 Patients in the mindfulness meditation intervention group demonstrated significantly lower scores on total mood disturbance by 65% and sub-scales of depression, anxiety, anger and confusion compared with control participants. The treatment group demonstrated less stress symptoms (by 31%), fewer cardiopulmonary and gastrointestinal symptoms, and less emotional irritability and cognitive disturbances. A recent preliminary study investigating mindfulness-based stress reduction reported that participation in the program was associated with enhanced quality of life and decreased stress symptoms, altered cortisol and immune patterns consistent with less stress and mood disturbance, and decreased blood pressure.34
Relaxation therapy
A recent Cochrane review and meta-analysis of 15 trials with 11 included in the analysis demonstrated that relaxation was effective for reducing depressive symptoms.35 Five trials showed relaxation reduced self-reported depression compared to wait-list, no treatment, or minimal treatment post-intervention (SMD −0.59 [95% confidence interval [CI] −0.94 to −0.24]). For clinician-rated depression, 2 trials showed a non-significant difference in the same direction (SMD −1.35 [95% CI −3.06 to 0.37]). A recent assessment of the Cochrane review concluded relaxation techniques were better than either wait-list, no treatment or minimal treatment, but not as effective as psychological therapies such as CBT.36
Music therapy
A recent Cochrane review identified 4 studies that reported greater reduction in symptoms of depression among those randomised to music therapy than to those in standard care conditions.37 A fifth study showed no benefit. Overall there were low dropout rates from music therapy. The Cochrane review reported that music therapy was accepted by people with depression and was associated with improvements in mood.37 However, the review cited that the trials reviewed were small in number and that they had low methodological quality. Hence, it was not possible to be confident about the effectiveness of music therapy in the treatment of depression. High quality trials evaluating the effects of music therapy on depression are thus required.
Religion and spiritual health
Healthy religious beliefs may assist older patients with depression after a medical illness by providing comfort, support and improved coping strategies to help them manage, according to a US study.38 In the study, 94 patients aged 60 and older diagnosed with depression during a hospital admission for a physical complaint, were more likely to recover from depression if they had expressed religious beliefs. In a further US study,39 with data from 2600 male and female twins, has reported a strong association between religious beliefs and a lower intake of alcohol, nicotine and drug dependence or abuse, with less effects on depression. However, in a recent study 503 patients participating in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) trial completed a Daily Spiritual Experiences (DSE) questionnaire within 28 days from the time of their acute myocardial infarction (AMI). The results showed little evidence that self-reported spirituality, frequency of church attendance, or frequency of prayer is associated with cardiac morbidity or all-cause mortality post-AMI in patients with depression and/or low perceived support.40
Health practitioners require awareness of the potential role of spirituality, religiosity and depression.41 This field of evidence is important so as to provide a more holistic approach to psychotherapy treatment.41 Whilst many studies link a lack of religiosity to depression, one important factor is that it may be a lack of meaning and spiritual fulfilment that is part of the increasingly secular and materialistic society contributing to the increased incidence of depression in the Western countries.
A US study42 of 160 terminally ill cancer patients in a catholic palliative care hospital found that spiritual wellbeing offered some protection against end-of-life despair and depression. The study demonstrated the importance of spiritual wellbeing in reducing psychological distress, in particular in palliative care practice.
Family support
An Australian study with terminally ill patients in a catholic hospice reported that family support was correlated with no documented requests for euthanasia, a surrogate marker for possible enhanced depressive dispositions.43
Early studies that include a review of the literature have indicated that a healthy marriage is beneficial for both mental (especially depression) and physical health.44 Also that a healthy marriage is equally protective for both men and women.45
Sleep disturbance
Whilst sleep disturbance is common in patients with depression, there is a growing body of evidence to suggest that sleep deprivation may be a contributor to depression.46, 47
In an Australian Melbourne study, 86 patients aged 16–88 years (average age = 42 years; female participants = 54%) presented as suffering from chronic insomnia, of which two-thirds were also suffering from depression.48 Participants were then introduced to a self-help program (a book and 3 audiocassettes), and a manual to assist in non-drug approaches to sleep, which they used at home to improve their sleep. At follow-up, 6–8 weeks later, 70% of the insomnia sufferers who were depressed before treatment and learned to sleep better were no longer depressed, or were significantly less depressed, once their sleep had improved. An additional 13%, while still depressed, had a reduction of at least 40% in their depression scores. By contrast, among people who did not learn to sleep better, none experienced a significant reduction in depression. This study strongly suggests that, for many people who suffer from both depression and insomnia, treating the insomnia successfully without medication may eliminate or significantly reduce their depression. Further, just over half of those participants who were using antidepressant medications at the initial interview had ceased using it by follow-up, were sleeping significantly better, and were no longer depressed. Whilst the findings of this research are quite impressive, more research in this area is required.
Another Australian Melbourne study at the Royal Children’s Hospital using a screening questionnaire of 738 mothers with infants 6–12 months of age, also suggested that sleep deprivation was a contributor to post-natal depression (PND).49 If the mother reported a problem with their child’s sleep, they were twice as likely to score the PND threshold than mothers who did not report a problem. Mothers reporting good sleep, despite an infant sleep problem, were not more likely to develop depression. A further study by the same group demonstrated that by treating the mothers’ sleep using behavioural interventions, the depression score was reduced significantly as reported in a randomised control trial of 156 mothers with infants aged 6–12 months.50 This benefit was sustained at 2 months and at 4 months for mothers with high depression scores.
A sample study of 5692 US adults, found those who reported sleeping difficulties such as initiating or maintaining sleep and early morning awakening, was associated with a two-fold increase risk of suicidality than participants without sleep disturbance.51 Chronic sleep problems were found to be an independent risk factor for depression and suicidality, so it would appear addressing sleep problems could play an important role in prevention of depression and suicidality.
A recent interventional study reported that a sleep intervention program implemented in infancy resulted in sustained positive effects on maternal depression symptoms and found no evidence of longer-term adverse effects on either the mothers’ parenting practices or the children’s mental health.52 This intervention demonstrated the capacity of a functioning primary care system to deliver an effective and universally offered secondary prevention program.
Adequate sleep is essential for general health. A study has found that sleep deprivation combined with light therapy was useful in the treatment of drug resistant bipolar depression.53 The response was effective for acute and long-term remission rates. (See Chapter 22 on insomnia and sleep disorders.)
Sunshine
Vitamin D
Sunshine is the main source of vitamin D produced by the body in response to direct skin exposure to UVB. This means that no or minimal exposure to sun can contribute to vitamin D deficiency as seen in community groups with dress codes (e.g. wearing veils), living in geographical prone areas (e.g. in high and low altitudes) especially over winter, working indoors (e.g. office work), institutionalisation, prolonged hospitalisation and bed-bound people, and particularly in dark skin people who need longer sun exposure.54, 55 Vitamin D deficiency especially over winter with lower sun exposure is linked with lower moods, depression and seasonal affective disorder. Increasing sun exposure and supplementation with vitamin D3 can improve moods.56, 57
Light therapy
Light therapy is a physical intervention that is used to treat depression and depressive disorders such as bipolar.53 Cognitive decline, mood, behavioural and sleep disturbances, and limitations of activities of daily living commonly burden patients, especially the elderly with cognitive deficits.58 Circadian rhythm disturbances have been associated with these symptoms.58 Light therapy exposes patients to a bank of bright lights for a variable number of hours per day, usually 1–3 hours. Patients can engage in activities during the period of exposure, such as reading and computer use or relaxation time. In a recent study that reviewed CM therapies in the treatment of depression in children and adolescents, Jorm and colleagues59 have described good evidence for the efficacy of light therapy in winter depression. There was, however, no evidence that it would be effective for non-seasonal depression.
Studies suggest that light therapy may be beneficial when used as an adjunct with other treatments.60, 61 Results from 1 study indicate that there was a positive total sleep deprivation response in major depression patients which can be predicative of beneficial outcome of subsequent light therapy.60 In a further study, bright light therapy was significantly beneficial compared to placebo for the treatment of depression.61 It augmented antidepressant effects of medication and wake therapy.61 Furthermore, in patients with dementia, light therapy was demonstrated to have a modest benefit in improving some cognitive and non-cognitive symptoms of dementia in a randomised control trial with melatonin supplement.62 To counteract the adverse effect of melatonin on mood, the study recommended its prescriptive use only in combination with light therapy.
However, in a recent study antidepressant response to bright light treatment in older adults was not statistically superior to placebo. Both treatment and placebo groups experienced a clinically significant overall improvement of 16%.63 There is very limited data which is currently available, suggesting that further research is warranted.
Environment
Smoking and smoking cessation
Whilst it is well recognised that depression is a major risk factor for smoking and there is a strong relationship between mental disorders and smoking,64, 65 according to a prospective study66 of more than 15 000 teenagers, smokers were 4 times more likely to develop depressive symptoms over a 1-year period than teenagers who did not smoke. The strong association remained even after accounting for other risk factors (e.g. low socioeconomic status and low self-esteem). The study reports that smoking itself may be a cause for depression via the activity of nicotine on the central noradrenergic receptor systems. Recently it has been reported that there is a relationship between smoking status and continuously distributed depressed mood among a cohort of adolescents.67 Moreover, the relationship between cigarette smoking and depression may be a factor in the development of subsequent dependence.67 It would appear that advising against heavy or any cigarette intake may be useful for the management of depression.
Substance abuse and drug intake
Substance abuse and drug intake is common in depression. About one-third of patients with major depressive disorders also have substance use disorders, associated with higher risk of suicide and greater social and personal impairment as well as other psychiatric conditions.68
Physical activity
Exercise
There is strong evidence to support the benefits of exercise in the prevention and alleviation of symptoms of depression. Although data from randomised trials are limited, results of studies included in a recent review generally support use of exercise as an alternative or adjunctive treatment for depression.69
Early reports highlight the benefits that regular physical activity provides in reducing the risk of developing depression.70 People who do not participate in physical activity are more likely to develop depression compared with those who regularly exercise.71 Regular aerobic and strength training activities can lead to 50% reduction in symptoms of acute depression and anxiety, especially in women and older people.72 Physical activity is equally as effective as some pharmacological treatment (e.g. sertraline) in the management of mild–moderate depression, especially in the elderly. A 10-month study of 156 adult volunteers with major depressive disorders randomly assigned participants to a course of aerobic exercise, sertraline therapy, or a combination of exercise and sertraline. After 4 months all treatment groups exhibited significant therapeutic improvement and after 10 months, the exercise group had significantly lower relapse rates than participants on sertraline therapy alone.73
A Scottish study randomised 86 patients older than 53 with depression and not responding to at least 6 weeks of antidepressants, to twice-weekly group exercise classes (45 minutes of predominantly weight-bearing exercise) or health education talks for 10 weeks.74 Fifty-five percent of the patients in the exercise group compared with 33% in the education talk group experienced a decline of at least 30% in their depressive symptoms. This study suggests that patients with depression should be actively encouraged to attend group exercise activities and regular physical activity, such as aerobic classes, or an early morning walk of greater than 60 minutes daily. This would at least also take advantage of sunshine exposure or light therapy even on overcast winter days.75
Exercise has been demonstrated to also improve mood in patients with severe affective disorders, according to a small pilot study of 12 participants.76 The study concluded that exercise produced changes in concentration of several biologically active molecules such as adrenocorticotrophic hormone, cortisol, catecholamines, opioid peptides, and cytokines, which have been reported to affect mood or are involved in the physiopathology of affective disorders.77 Moreover, endurance exercise may help to achieve substantial improvement in the mood of selected patients with major depression in the short time.78 Also, there is sufficient evidence to support appropriate physical activity as an intervention to enhance a cancer patient’s physical functioning and psychological wellbeing.79
A recent Cochrane review evaluated 28 trials which fulfilled the inclusion criteria, and of which 25 provided data for the meta-analyses.80 Randomisation was adequately concealed in only a few of the studies, and most did not use intention to treat analyses. Also most of the studies used self reported symptoms as outcome measures. For the 23 trials consisting of 907 participants comparing exercise with no treatment or a control intervention, the pooled SMD was −0.82 (95% CI –1.12, −0.51), indicating a large clinical effect. However when trials with robust designs only were included in the analysis namely, adequate allocation concealment and intention to treat analysis and blinded outcome assessment, the pooled SMD was −0.42.95% CI −0.88, 0.03 that is a moderate, non significant effect was observed.80Hence the study concluded that physical activity gives the impression to improve depressive symptoms in people with a diagnosis of depression, but when only methodologically robust trials are included, the effect sizes are only moderate and not statistically significant. Further robust trials are warranted. Further analysis of the Cochrane review confirmed exercise may improve depression but the majority of trials again had weaknesses.2
Yoga
An early study81 has demonstrated that the daily practice of yoga was able to significantly improve symptoms of depression, and in 1 randomised study was statistically as effective as ECT and imipramine.82 Another study of men and women found yoga significantly improved mood scores for depression and other psychological states such as anxiety, anger and ‘neurotic symptoms’.83
A review of the evidence reveals that yoga has potentially beneficial effects as an intervention on depressive disorders.46 Variation in interventions, severity and reporting of trial methodology suggests that the findings must be interpreted with caution. A number of the interventions may not be feasible in those with reduced or impaired mobility and, even so, further investigation of yoga as a therapeutic intervention is warranted.
Nutritional influences
Nutrition and diets
Chocolate
Dark chocolate may play a role in mood enhancement. One study demonstrated that older men who ate chocolate showed statistically significant improvement in feelings of loneliness, happiness, having plans for the future, less depression, better health, optimism and better psychological wellbeing compared with men who ate candy.84
Lactose and/or dairy
Diet plays an equally important role in the management of depression. As an example, lactose malabsorption may play a role in the development of depression.85 Lactose malabsorption is characterised by a deficiency of mucosal lactase (an enzyme) and, as a consequence, lactose that reaches the colon is broken down by bacteria to short-chain fatty acids, CO2, and H2. Bloating, cramps, osmotic diarrhoea, and other symptoms of irritable bowel syndrome (IBS) are the consequence and can be seen in about 50% of lactose malabsorbers. Thirty women aged 16–60 were all screened for depression using a questionnaire. The group with lactose malabsorption (n = 6 compared with 24 normal lactose absorbers) had significantly higher scores on the depression questionnaire compared with normal lactose absorbers. The study postulated that lactose malabsorption may cause high intestinal lactose levels that might interfere with L-tryptophan metabolism by binding with L-tryptophan and impeding its absorption, and in turn affect serotonin synthesis and availability.85 Although more research is warranted, lactose malabsorption in patients with signs of mental depression, particularly in those with digestive problems, should be considered.
Seafood consumption
Seafood consumption has been reported to be associated with a lower prevalence of bipolar disorder, according to a systematic review.86 A US-based study reviewed population-based epidemiological studies from 17 countries and found greater rates of seafood consumption (n-3 fatty acids) were associated with lower lifetime prevalence for bipolar I, bipolar II, and bipolar spectrum disorders. Greater seafood consumption (deep sea) was also related to lower lifetime prevalence of major depression in 9 countries.86
General diet advice
Consequently, the general advice for depressed patients would include eating regular, balanced healthy meals, high in fruit, vegetables and deep sea fish (at least 2–3 times per week). Poor dietary choices have been reported to be associated with the development of depressive symptoms.87
Alcohol
Whilst depression can lead to excessive alcohol intake, a cohort study of 1055 individuals followed up from birth to 25 years of age found a clear association of heavy alcohol consumption and alcohol abuse increasing the risk of major depression by 65% after controlling for confounding factors. The authors postulated that alcohol may act as a trigger for genetic markers that increase the risk of mental disorders.88
Nutritional supplements
Fish oils and/or omega-3 (n-3) fatty acids
Fish oil supplementation may play a role in the management of depression and bipolar disorder.
Bipolar disorder
In an early preliminary 4-month double-blind, placebo-controlled trial 30 patients with bipolar disorder were randomised to receive either n-3 fatty acids (9.6 g/day) or placebo (olive oil), in addition to their ongoing treatment.89 The n-3 fatty acids were well tolerated and the group of patients that took n-3 fatty acids had significantly longer periods of remission than the placebo group and a reduction in depressive symptoms over the 4 months of treatment.
A small open label study of bipolar outpatients with depressive symptoms also improved significantly within 1 month of treatment with 1.5–2 g/day of Eicosapentaneoic acid (EPA) with no patients developing hypomania or manic symptoms or side-effects with treatment. The authors concluded that the fatty acids may play a role by regulating neurotransmitter metabolism and larger well-controlled trials are necessary.90
Depression
Several trials indicate omega-3 deficiency may contribute to depression and psychiatric diseases, and dietary fish intake and fish oil supplementation may play a useful role in the management of depression.91, 92
In a case control study of pregnant women, women with lower omega-3 PUFA levels especially due to low dietary intake and fetal diversion, were 6 times more likely to experience depression antenatally, compared with women with higher levels.93 The authors conclude there is a role for increased fish intake and fish oil supplementation during the perinatal period.
In 1 study of middle-aged women with moderate-to-severe psychological distress and depression during the menopausal transition (n = 120), participants were randomly assigned to receive 1.05g ethyl-EPA/d plus 0.15g of ethyl-docosahexaenoic acid/d (n = 59) or placebo (n = 61) for 8 weeks.94
Two recently reported trials with the essential fatty acid eicosapentaenoic acid (EPA) have demonstrated efficacy in depression.95, 96 One study compared the administration of EPA to fluoxetine in major depression and reported that the combination was significantly more effective than EPA or fluoxetine administered separately.96
A review of treatments of depression in children and adolescents identified 1 trial of omega-3 PUFA supplementation was beneficial in depressed children compared with placebo.97
A recent meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of n-3 fatty acids has demonstrated efficacy with a cautionary note.95 Although the meta-analysis showed significant antidepressant efficacy of n-3 PUFAs, it is still premature to validate this finding due to publication bias and heterogeneity of studies available. Large scale, well-controlled trials are needed to find out the favourable target subjects, therapeutic dose of EPA, and the composition of n-3 PUFAs in treating depression.98
Recently, Mischoulon reported that the results of n-3 fatty acid supplementation studies, was promising in the treatment of depression.99 In addition, the n-3 fatty acids have been shown to be safe and might be useful in specific populations, such as the elderly, pregnant or lactating women, and people with medical comorbid conditions. Moreover, patients with mild depression or those who are unresponsive to conventional antidepressants might be the best candidates for alternative treatments such as St John’s Wort (SJW) and n-3 fatty acids.99
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
